CN114796070A - Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof - Google Patents
Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof Download PDFInfo
- Publication number
- CN114796070A CN114796070A CN202210397859.5A CN202210397859A CN114796070A CN 114796070 A CN114796070 A CN 114796070A CN 202210397859 A CN202210397859 A CN 202210397859A CN 114796070 A CN114796070 A CN 114796070A
- Authority
- CN
- China
- Prior art keywords
- extract
- preparation
- concentrated
- ethanol
- wound healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000029663 wound healing Effects 0.000 title claims abstract description 17
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 12
- 230000003110 anti-inflammatory effect Effects 0.000 title claims description 9
- 230000006870 function Effects 0.000 claims abstract description 12
- 230000008439 repair process Effects 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 12
- 208000027418 Wounds and injury Diseases 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 206010052428 Wound Diseases 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 229940067866 dandelion extract Drugs 0.000 claims description 7
- 235000020691 dandelion extract Nutrition 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 229940076591 saffron extract Drugs 0.000 claims description 6
- 241000723435 Chamaedaphne Species 0.000 claims description 5
- 235000015655 Crocus sativus Nutrition 0.000 claims description 5
- 244000124209 Crocus sativus Species 0.000 claims description 5
- 241000736199 Paeonia Species 0.000 claims description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 5
- 235000013974 saffron Nutrition 0.000 claims description 5
- 239000004248 saffron Substances 0.000 claims description 5
- 241000245665 Taraxacum Species 0.000 claims description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 244000236658 Paeonia lactiflora Species 0.000 claims description 3
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 3
- 208000014674 injury Diseases 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 230000008736 traumatic injury Effects 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 6
- 230000009285 allergic inflammation Effects 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 description 28
- 239000000047 product Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 6
- 230000007815 allergy Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 241000510764 Villosa Species 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 238000001647 drug administration Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 231100000057 systemic toxicity Toxicity 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000249442 Anthyllis vulneraria Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A composition with repair function, anti-inflammation, anti-allergy and wound healing functions is prepared by a preparation method, and comprises a composition of at least four substances of the following components: the preparation method is simple to operate, convenient to obtain raw materials, high in synthesis efficiency, mild in drug property, not prone to generate side effects, and remarkable in allergic inflammation treatment and relieving effect.
Description
Technical Field
The invention is mainly applied to the field of skin antiallergic maintenance, and particularly relates to an anti-inflammatory antiallergic wound healing flower composition with a repairing function and a preparation method thereof.
Background
The manifestation form of skin allergy is mostly erythema, pimple, blister and the like, the skin allergy population has more induction factors, is easy to relapse and is difficult to radically treat, the current means for treating and relieving allergic inflammation is an antibiotic treatment method, but the problems of the antibiotic treatment inflammation are as follows: when the antibiotics are used, the organism is easy to generate drug resistance, and the drug effect is gradually reduced; "it is three fens poison of medicine", the antibiotic treats inflammation and produces the minus effect, can't use for a long time; the treatment effect is not ideal, the repeated attack is easy, and the radical treatment cannot be realized, so that the finding of an anti-inflammatory and antiallergic agent which is green, safe and has no recurrence to replace antibiotics is very important.
Aiming at the existing problems, the invention relates to a composition with repair function, anti-inflammation, anti-allergy and wound healing effects and a preparation method thereof, and particularly, pure natural plants of dandelion, saffron, villus spicata and peony root are used, and the extraction and purification preparation method is adopted to extract and combine the effective components in the four plants for treating and relieving skin allergy inflammation.
The technical scheme of the invention is as follows: a composition with repair function for anti-inflammatory and anti-allergic wound healing, which is prepared by a preparation method and comprises a composition of at least four substances with the following components: herba Taraxaci extract, stigma croci Sativi extract, flos Clerodendri Japonici, radix Paeoniae extract, and further mixing the herba Taraxaci extract, stigma croci Sativi extract, flos Clerodendri Japonici, and radix Paeoniae extract at a certain ratio.
Further, the dandelion extract is obtained by extracting dandelion with ethanol three times, concentrating the extract to remove ethanol, and purifying and concentrating the eluate until white powder of the extract is precipitated.
Further, extracting saffron with ethanol for three times, concentrating the extractive solution for dealcoholization, decolorizing with activated carbon, concentrating, and drying to obtain powder.
Further, the villus flowers for wound healing are soaked and extracted by adopting butanediol and deionized water, and are decolorized after being leached.
Furthermore, the preparation of the saffron extract and the villus pini extract for wound healing adopts an ultrasonic crushing method and a low-temperature cold extraction method.
Further, radix paeoniae alba is extracted for three times by ethanol, extract liquor is concentrated, adsorption and purification are carried out by resin after concentration, decoloration and drying are carried out after purification, and powder is obtained.
Further, mixing herba Taraxaci extract, stigma croci Sativi extract, flos Windmillae Chamaedaphnes and radix Paeoniae extract at a certain proportion, dissolving in deionized water, stirring thoroughly, and filtering for several times to obtain clear transparent product.
A composition with repair function for anti-inflammatory and anti-allergic wound healing, further comprises at least four materials: herba Taraxaci extract, stigma croci Sativi extract, flos Windmillae Chamaedaphnes, and radix Paeoniae extract.
The invention has the beneficial effects that: (1) the preparation method has the advantages that the raw material resources are rich, the distribution is wide, byproducts are not generated in the extraction process, the green and environment-friendly effects are realized, (2) the dissolubility of each component in the raw materials is improved through extraction, concentration and purification treatment, the high-purity product is obtained at high extraction efficiency, (3) the raw material extract is simple to operate, the equipment repeatability is high, the experimental conditions are easy to regulate and control, and the preparation is suitable for large-scale low-cost industrial production, (4) and obviously relieves allergic symptoms in practical use.
Drawings
FIG. 1 is a production flow diagram of the process of the present invention;
FIG. 2 is a graph showing the simulation of allergic inflammatory response to histamine 0.5% for 20 minutes;
FIG. 3 is a plot of the position of a 2% application of a formulation of the invention and a 0.5% application of a formulation of the invention:
FIG. 4 is a graph showing the effect of the coating after 5 minutes;
fig. 5 is a graph of the effect after 15 minutes of smearing.
Detailed Description
The following embodiments and effects of the present invention are further described with reference to the following examples:
as shown in fig. 1, a preparation method of a composition for anti-inflammatory, anti-allergic and wound healing with a repairing function comprises a composition of at least four substances consisting of: herba Taraxaci extract, stigma croci Sativi extract, flos Windmillae Chamaedaphnes, and radix Paeoniae extract.
In a preferred embodiment, the dandelion extract is obtained by extracting dandelion with ethanol three times, concentrating the extract to remove ethanol, and purifying the concentrated eluate until white powder of the extract is precipitated.
In a preferred embodiment, the saffron is extracted with ethanol for three times, the extract is concentrated and dealcoholized, and then decolorized with activated carbon, concentrated and dried to form powder.
In a preferred embodiment, the villus of the wound is soaked and extracted by butanediol and deionized water, and decoloration treatment is carried out after extraction.
In a preferred embodiment, the saffron extract and the villus collina extract are prepared by adopting an ultrasonic crushing method and a low-temperature cold extraction method.
In a preferred embodiment, the radix paeoniae is extracted three times by ethanol, the extract is concentrated, and then is adsorbed and purified by resin, and then is concentrated, decolored and dried into powder after being purified.
In a preferred embodiment, the dandelion extract, the saffron extract, the herb of glabrous greenbrier and the peony root extract are mixed in proportion, dissolved in deionized water and stirred fully, and then filtered for a plurality of times until the mixture is clear and transparent.
In the preparation method, the dandelion extract, the saffron extract, the villus villosa extract for wound healing and the peony root extract are mixed according to the proportion, dissolved in deionized water, stirred, filtered, clarified and transparent, and the preparation used in the mixing process and the preferable proportion of the preparation are as follows: 50% of water, 10% of butanediol, 15% of villus villosa extract, 5% of saffron extract, 10% of dandelion extract, 9% of peony root extract and 1% of ethylene glycol.
A composition with repair function for anti-inflammatory and anti-allergic wound healing, further comprises four material substances: herba Taraxaci extract, stigma croci Sativi extract, flos Windmillae Chamaedaphnes, and radix Paeoniae extract.
The preparation of the invention is prepared in the following actual experimental process:
as shown in figure 2, 0.5% histamine is used for stimulating for 20 minutes to simulate allergic inflammatory reaction, the arms of experimenters have developed the allergic inflammatory reaction, then as shown in figure 3, 2% of the preparation of the invention is coated at a mark a, 0.5% of the preparation of the invention is coated at a mark b, the coated medicament is neutral diluted liquid except the content of the preparation of the invention, as shown in figure 4, after five minutes, pruritus inflammatory symptoms are weakened in the coated area of the preparation of the invention, and symptoms are aggravated in the non-coated area, as shown in figure 5, the part a coated with 2% of the preparation of the invention and the part b coated with 0.5% of the preparation of the invention have obviously relieved allergy, and the symptom relieving effect of the part a coated with 2% of the preparation of the invention is obviously better than that of the part b coated with 0.5% of the preparation of the invention, thus proving that the preparation of the invention can effectively relieve the symptoms of allergic inflammation.
Furthermore, the preparation of the invention can be added into cosmetics according to a certain proportion in the actual using process to enhance the anti-allergy property of the cosmetics and increase the effect of eliminating allergic inflammation of the cosmetics, and the actual proportion is as follows.
Component 1: according to catalog of used cosmetic raw materials (2021 edition) published by the national drug administration, the highest use concentration of the component in resident products is 97.966%, the recommended addition amount of a Bio Rmd Factor allergy and injury Factor (version number 001) in cosmetics is 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.932% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
And (2) component: butanediol, according to catalog of used cosmetic raw materials (2021 edition) issued by the State administration of medicine, the highest use concentration of the component in resident products is 87.98%, the recommended addition amount of the Bio-Rmd Factor repair and wound healing Factor (version number 001) in cosmetics is 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.224% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
And (3) component: herb extract of malva villosa (ANTHYLLIS VULNERARIA), systemic toxicity: the herb of villous downy rosea of healing wound belongs to a natural flavoring compound published by the international food flavor Industry Organization (IOFI), and the number is as follows: COE 51, useful as a food flavoring agent. According to the book Edable and Medicinal Plants, it is mentioned that the Fuzz flower of healing wound is an Edible plant, and the flower can be used as a substitute of tea. The exposure amount generated by food intake in daily diet is much higher than that generated by cosmetic intake, and the ingredient is judged to have lower risk of causing systemic toxicity when being used in cosmetics, thereby meeting the safety requirement;
local toxicity: according to the toxicological test report, the results of the acute eye irritation test using undiluted raw material (herb villosa extract 18%) were: results of non-irritant and acute skin irritation tests: no irritation, multiple skin irritation test results: the composition has no irritation, and the risk of local adverse reactions caused by the composition when the composition is used in cosmetics is judged to be low, so that the safety requirement is met;
in conclusion, the component has low risk of causing systemic toxicity and local skin toxicity when being used in cosmetics, and can be safely used.
[1]Global Reference List of Natural Complex ubstances/Natural Flavouring Complexes,08/11/2021,https://www.flavordata.com/grl/download/ncs.
[2] Launert. E. Edible and Medicinal Plants. Hamlyn 1981 ISBN 0-600-37216-2 Covers plants in Europe. a drawing of each plant, quite a bit of interesting information.
And (4) component: according to catalog of used cosmetic raw materials (2021 edition) issued by the State drug administration, the highest use concentration of the component in resident products is 0.35%, the Bio-Rmd Factor repair and wound treatment Factor (version number 001) is suggested to be added into cosmetics in an amount of 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.07% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
And (5) component: according to catalog of used cosmetic raw materials (2021 edition) issued by the State administration of medicine, the highest use concentration of the component in resident products is 0.288%, the Bio-Rmd Factor repair and wound healing Factor (version number 001) is suggested to be added into cosmetics in an amount of 0.2-2%, the actual component content of the component 1 in the cosmetics is 0.2% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
And (4) component 6: the extract of the root of Paeonia lactiflora (Paeonia ALBIFLORA) is prepared according to catalog of used cosmetic raw materials (2021 edition) published by the State drug administration, the highest use concentration of the component in resident products is 2.45%, the recommended addition amount of a Bio-Rmd Factor allergy and injury Factor (version number 001) in cosmetics is 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.2% calculated according to the maximum addition amount of 2%, and the application risk of the extract is within an acceptable range.
And (4) component 7: according to catalog of used cosmetic raw materials (2021 edition) issued by the State administration of medicine, the highest use concentration of the component in resident products is 1.006%, the recommended addition amount of a Bio-Rmd Factor allergy and wound healing Factor (version number 001) in the cosmetics is 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.004% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
And (4) component 8: 1, 2-hexanediol, according to catalog of used cosmetic raw materials (2021 edition) issued by the State drug administration, the maximum use concentration of the component in the resident products is 66.05%, the Bio-Rmd Factor repair and wound healing Factor (version number 001) is recommended to be added in the cosmetics in an amount of 0.2% -2%, the actual component content of the component 1 in the cosmetics is 0.01% calculated according to the maximum addition amount of 2%, and the application risk is within an acceptable range.
The above-mentioned factor for repairing allergy and healing wound is a composition preparation with the function of repairing inflammation, resisting allergy and healing wound of the invention.
Although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications, substitutions and the like can be made thereto without departing from the spirit and scope of the invention.
Claims (8)
1. The preparation method is characterized by comprising the following composition of at least four substances: herba Taraxaci extract, stigma croci Sativi extract, flos Clerodendri Japonici, and radix Paeoniae extract by mixing at a certain ratio.
2. The method according to claim 1, wherein the dandelion extract is obtained by extracting dandelion with ethanol three times, concentrating the extract to remove ethanol, and purifying the concentrated eluate until white powder of the extract is precipitated.
3. The process according to claim 1, wherein saffron is extracted three times with ethanol, the extract is concentrated and dealcoholized, then decolorized with activated carbon, concentrated and dried to powder.
4. The preparation method according to claim 1, wherein the villus of wound is extracted by soaking with butanediol and deionized water, and decolorized after leaching.
5. The process according to any one of claims 3 or 4, wherein the saffron and the villus of wound are prepared by ultrasonic crushing and cold extraction at low temperature.
6. The method of claim 1, wherein the paeonia lactiflora is extracted with ethanol three times, the extract is concentrated, and then is purified by adsorption with a resin, and then is concentrated, decolorized and dried to powder.
7. The method of claim 1, wherein the dandelion extract, the saffron extract, the herb of villus of traumatic injury, and the peony root extract are mixed in proportion, dissolved in deionized water, stirred thoroughly, and then filtered several times to obtain a clear and transparent product.
8. The composition with repair function, anti-inflammatory and anti-allergic wound healing function is characterized by at least comprising four material substances: herba Taraxaci extract, stigma croci Sativi extract, flos Windmillae Chamaedaphnes, and radix Paeoniae extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210397859.5A CN114796070A (en) | 2022-04-08 | 2022-04-08 | Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210397859.5A CN114796070A (en) | 2022-04-08 | 2022-04-08 | Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114796070A true CN114796070A (en) | 2022-07-29 |
Family
ID=82535994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210397859.5A Pending CN114796070A (en) | 2022-04-08 | 2022-04-08 | Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114796070A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115364023A (en) * | 2022-08-09 | 2022-11-22 | 广州市千邦化妆品有限公司 | Acne removing essence and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107469064A (en) * | 2016-06-08 | 2017-12-15 | 广州艾玫格生物科技有限公司 | Biological antiallergic compound |
CN109939043A (en) * | 2017-12-21 | 2019-06-28 | 香奈儿香水美妆品公司 | The alcohol extracting thing of lady's-finger aerial part obtains its method and cosmetics or pharmaceutical composition comprising it |
CN111150689A (en) * | 2020-01-21 | 2020-05-15 | 广州睿森生物科技有限公司 | Composition containing villus flowers for treating wounds and application of composition |
CN111728907A (en) * | 2020-06-30 | 2020-10-02 | 广州市科能化妆品科研有限公司 | Soothing and anti-allergy composition, preparation method thereof and application thereof in cosmetics |
CN112842954A (en) * | 2020-03-23 | 2021-05-28 | 上海铮信生物科技有限公司 | Anti-inflammatory and soothing composition and application thereof in cosmetics |
CN113440461A (en) * | 2021-06-23 | 2021-09-28 | 植物医生(广东)生物科技有限公司 | Soothing and allergy-reducing composition and application thereof |
CN114224799A (en) * | 2021-12-27 | 2022-03-25 | 南宁维康医药科技有限公司 | Composition for anti-allergy repair and preparation method and application thereof |
-
2022
- 2022-04-08 CN CN202210397859.5A patent/CN114796070A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107469064A (en) * | 2016-06-08 | 2017-12-15 | 广州艾玫格生物科技有限公司 | Biological antiallergic compound |
CN109939043A (en) * | 2017-12-21 | 2019-06-28 | 香奈儿香水美妆品公司 | The alcohol extracting thing of lady's-finger aerial part obtains its method and cosmetics or pharmaceutical composition comprising it |
CN111150689A (en) * | 2020-01-21 | 2020-05-15 | 广州睿森生物科技有限公司 | Composition containing villus flowers for treating wounds and application of composition |
CN112842954A (en) * | 2020-03-23 | 2021-05-28 | 上海铮信生物科技有限公司 | Anti-inflammatory and soothing composition and application thereof in cosmetics |
CN111728907A (en) * | 2020-06-30 | 2020-10-02 | 广州市科能化妆品科研有限公司 | Soothing and anti-allergy composition, preparation method thereof and application thereof in cosmetics |
CN113440461A (en) * | 2021-06-23 | 2021-09-28 | 植物医生(广东)生物科技有限公司 | Soothing and allergy-reducing composition and application thereof |
CN114224799A (en) * | 2021-12-27 | 2022-03-25 | 南宁维康医药科技有限公司 | Composition for anti-allergy repair and preparation method and application thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115364023A (en) * | 2022-08-09 | 2022-11-22 | 广州市千邦化妆品有限公司 | Acne removing essence and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101054378B1 (en) | Herbal soap composition and its manufacturing method | |
CN104258193A (en) | Drug composition for treating neurasthenia and preventing senile dementia | |
KR101844849B1 (en) | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing | |
CN114796070A (en) | Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof | |
CN111053818A (en) | Health care product for adjuvant treatment of skin itch and preparation method thereof | |
CN112754013A (en) | Green money poria cocos health-care particles and preparation method thereof | |
EP0967988A1 (en) | Ointment for the treatment of burns and of other skin diseases | |
CN113040177A (en) | Plant fermentation extract for degrading pesticide residues of crops and preparation method thereof | |
CN102389074B (en) | Dilong liquid containing various amino acids and preparation method thereof | |
CN102764416B (en) | Formula and preparation method of hair blackening preparation | |
CN110917232A (en) | Method for applying medical natural product targeted medicine of dandelion extracted by hydrothermal method to mainly treat dermatitis allergy | |
KR20150062553A (en) | Manufacturing method of composition of health food containing Ixeris Dentata extracts and composition of health food containing Ixeris Dentata extracts manufactured by the same | |
CN104255954A (en) | Abelmoschus manihot(L.) Medic. compound base seed oil and preparation method and application of abelmoschus manihot(L.) Medic. compound base seed oil | |
KR100373058B1 (en) | The method to make high functional brewed vinegar and high functional brewed vinegar made by the method | |
CN116747286B (en) | A Chinese medicinal composition with weight reducing effect, and its preparation method | |
KR102402980B1 (en) | Manufacturing method wood-cultivated ginseng gel | |
CN114917269B (en) | External hemostatic and preparation method thereof | |
CN103142718B (en) | Liquid medicine for treating freezing injury | |
Hassan et al. | Phytochemical and Ethnobotanical Effects of Aloe vera | |
CN108392535A (en) | A kind of burn and scald sprayer formulation and preparation method | |
KR20040011584A (en) | Chinese medicine composition and the process method, good for the atopic dermatitis | |
CN1270732C (en) | Diuretic stone-excreting medicine and its prepn. | |
CN105287977A (en) | Sweet basil herb and aloe composition and preparation as well as preparation method and application of sweet basil herb and aloe composition | |
CN118021636A (en) | Natural plant anti-drop liquid and preparation method thereof | |
CN1092975A (en) | Multi-acting skin-care cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220729 |
|
RJ01 | Rejection of invention patent application after publication |